P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1273-1274
10.1097/01.hs9.0000848416.66197.62